Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Non-small Cell Lung Cancer Stage IIIA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00019019
What this trial is testing

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more
National Institutes of Health Clinical Center (CC) 70
Testing effectiveness (Phase 2)Study completedNCT00003111
What this trial is testing

Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Yale University 10
Large-scale testing (Phase 3)Study completedNCT00002911
What this trial is testing

Marimastat in Treating Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
ILEX Oncology Services, Incorporated
Early research (Phase 1)Study completedNCT00986297
What this trial is testing

Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance Status

Who this might be right for
Lung Cancer
University of Texas Southwestern Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT01909752
What this trial is testing

Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
UbiVac 12
Large-scale testing (Phase 3)Active Not RecruitingNCT02486718
What this trial is testing

Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 1,280
Early research (Phase 1)Ended earlyNCT00356941
What this trial is testing

Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLC

Who this might be right for
Lung Cancer
Masonic Cancer Center, University of Minnesota 4
Testing effectiveness (Phase 2)UnknownNCT00452881
What this trial is testing

Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLC

Who this might be right for
Lung Cancer
National Cancer Center, Korea 151
Early research (Phase 1)Study completedNCT01172028
What this trial is testing

Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerEsophageal CancerGastric Cancer+4 more
University of Arizona 33
Testing effectiveness (Phase 2)UnknownNCT04541251
What this trial is testing

Neoadjuvant Camrelizumab, Nab-paclitaxel and Carboplatin in Stage IB-IIIA NSCLC

Who this might be right for
Lung Cancer, Non-small CellArtificial Intelligence
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 40
Testing effectiveness (Phase 2)Looking for participantsNCT04865250
What this trial is testing

Predicting Response to Neoadjuvant ATEZOLIZUMAB Plus Carboplatin/Nab Paclitaxel in Resectable Non-squamous NSCLC

Who this might be right for
NSCLC Stage IINSCLC, Stage IIIANSCLC Stage IIIB
University Hospital Heidelberg 20
Testing effectiveness (Phase 2)Study completedNCT02262325
What this trial is testing

Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IIA Non-small Cell Lung CancerStage IIB Non-small Cell Lung Cancer+2 more
Ohio State University Comprehensive Cancer Center 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06644313
What this trial is testing

Vebreltinib for Neoadjuvant in MET-altered Stage IIIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Potentially Resectable MET-altered Non-Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 31
Large-scale testing (Phase 3)UnknownNCT03372694
What this trial is testing

Efficacy Study of Comprehensive Rehabilitation Program Plus Chemotherapy in Postoperative NSCLC Patients

Who this might be right for
Non-small Cell Lung Cancer
Shanghai University of Traditional Chinese Medicine 354
Testing effectiveness (Phase 2)Study completedNCT00061854
What this trial is testing

Soblidotin in Treating Patients With Progressive Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Daiichi Sankyo
Not applicableWithdrawnNCT05412875
What this trial is testing

Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lung

Who this might be right for
Head and Neck Squamous Cell CarcinomaLung Non-Small Cell CarcinomaStage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8+15 more
Ohio State University Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01737502
What this trial is testing

Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung CarcinomaLung AdenocarcinomaRecurrent Non-Small Cell Lung Carcinoma+5 more
Mayo Clinic 29
Not applicableStudy completedNCT03736993
What this trial is testing

Metabolomics Predict Therapy Response

Who this might be right for
NSCLC, Stage IIIA
Hasselt University 160
Testing effectiveness (Phase 2)Active Not RecruitingNCT01629498
What this trial is testing

Image-Guided, Intensity-Modulated Photon or Proton Beam Radiation Therapy in Treating Patients With Stage II-IIIB Non-small Cell Lung Cancer

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage II Non-Small Cell Lung Cancer AJCC v7Stage IIA Non-Small Cell Lung Carcinoma AJCC v7+3 more
M.D. Anderson Cancer Center 146
Testing effectiveness (Phase 2)Study completedNCT03285321
What this trial is testing

Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Greg Durm, MD 105
Next Page